+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Drug Discovery Market 2019-2028

  • ID: 4896890
  • Report
  • October 2020
  • Region: Global
  • 223 pages
  • Triton Market Research

FEATURED COMPANIES

  • 3M Company
  • Agilent Technologies Inc
  • Astrazeneca plc
  • Boehringer Ingelheim
  • F Hoffmann-La Roche Ltd
  • Johnson & Johnson
  • MORE
MARKET OUTLOOK

According to the publisher, the global drug discovery market is expected to display a positive market trend over the forecast period of 2019-2028, exhibiting a CAGR of 6.50%.

The surge in lifestyle-oriented diseases and the advancements in technology are the main factors driving the growth of the global market. Along with this, the growing elderly population and the rising healthcare expenses are also adding to market growth. Furthermore, significant investments made by the healthcare industry to improve big data analytical capabilities and the rise in demand for specialty medicines are creating opportunities for growth. On the other hand, the delay in product launches and the restricted rate of growth due to generic drugs are impeding the growth of the studied market. Further, poor reimbursement policies in emerging nations and stringent regulations by the government are creating challenges in the growth path.

REGIONAL OUTLOOK

The global market for drug discovery covers the regions of Europe, North America, Latin America, the Asia-Pacific, and the Middle East and Africa.

North America is the leading region in the global market and holds the highest share. According to the World Health Organization (WHO), the rate of incidence of CVD, hypertension, CHD, stroke, and other heart-related diseases is the highest in this region. The interventional cardiology market is forecasted to grow the fastest in majority of the developed and developing economies. The growing prevalence of lifestyle-oriented diseases, increased spending on healthcare, and technological advancement in the field of cardiology are the key factors responsible for driving the drug discovery market growth in North America.

COMPETITIVE OUTLOOK

Some of the companies having their presence in this market are Becton Dickinson & Company (BD), Agilent Technologies Inc, Abbott Laboratories Inc, Antares Pharma Inc, Eli Lily and Company,3M Company, Johnson & Johnson, Boehringer Ingelheim, Sanofi, Merck & Co Inc, AstraZeneca Plc, F Hoffmann-La Roche Ltd, Pfizer Inc, GlaxoSmithKline LLC, Bayer AG, and Novartis.

3M is a globally renowned company, and has been present for more than 116 years. Some of its major business verticals include industrial, safety & graphics, healthcare, electronics & energy, and consumer. The company’s healthcare segment covers a vast market, including hospitals, medical clinics, dental clinics, and pharmaceuticals. 3M has a strong workforce of around 91,000 employees across the world, with business operations in 23 countries. This indicates the commendable dominance of the company in major areas.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • 3M Company
  • Agilent Technologies Inc
  • Astrazeneca plc
  • Boehringer Ingelheim
  • F Hoffmann-La Roche Ltd
  • Johnson & Johnson
  • MORE
1. Global Drug Discovery Market - Summary

2. Industry Outlook
2.1. Market Definition
2.2. Porter's Five Forces Model
2.2.1. Threats of New Entrants
2.2.2. Threat of Substitute Products
2.2.3. Bargaining Power of Buyers
2.2.4. Bargaining Power of Suppliers
2.2.5. Competitive Rivalry
2.3. Covid-19 and Its Impact on Drug Discovery Market
2.4. PESTLE Outlook
2.5. Regulatory Framework
2.6. Value Chain Outlook
2.7. Market Attractiveness Index
2.8. Key Insight
2.9. Market Drivers
2.9.1. Growing Aged Population
2.9.2. Technological Advancements
2.9.3. Rise in Healthcare Expenditure
2.9.4. Surge in Lifestyle-Oriented Diseases
2.10. Market Restraints
2.10.1. Delay in Product Launches
2.10.2. Restricted Growth Rate Due to Generic Drugs
2.11. Market Opportunities
2.11.1. Significant Investment by Healthcare Industries in Improving Big Data Analytical Capabilities
2.11.2. Rising Demand for Specialty Medicines
2.12. Market Challenges
2.12.1. Poor Reimbursements Policies in Emerging Nations
2.12.2. Stringent Government Regulations

3. Drug Discovery Market Outlook - by Drug Type
3.1. Small Molecule Drug
3.2. Biologic Drug

4. Drug Discovery Market Outlook - by Technology
4.1. High Throughput Screening
4.2. Biochips
4.3. Bioinformatics
4.4. Pharmacogenomics and Pharmacogenetics
4.5. Combinatorial Chemistry
4.6. Nanotechnology
4.7. Spectroscopy
4.8. Metabolomics
4.9. Other Technologies

5. Drug Discovery Market Outlook - by Service
5.1. Drug Metabolism and Pharmacokinetics (Dmpk) Services
5.2. Chemical Services
5.3. Biological Services
5.4. Other Pharmaceutical Services

6. Drug Discovery Market Outlook - by End-User
6.1. Research Institutes
6.2. Pharmaceutical Companies
6.3. Contract Research Organizations (Cros)
6.4. Other End-Users

7. Drug Discovery Market – Regional Outlook
7.1. North America
7.1.1. Market by Technology
7.1.2. Market by Drug Type
7.1.3. Market by Service
7.1.4. Market by End-User
7.1.5. Country Analysis
7.1.5.1. United States
7.1.5.2. Canada
7.2. Europe
7.2.1. Market by Technology
7.2.2. Market by Drug Type
7.2.3. Market by Service
7.2.4. Market by End-User
7.2.5. Country Analysis
7.2.5.1. The United Kingdom
7.2.5.2. France
7.2.5.3. Germany
7.2.5.4. Spain
7.2.5.5. Italy
7.2.5.6. Russia
7.2.5.7. Rest of Europe
7.3. Asia-Pacific
7.3.1. Market by Technology
7.3.2. Market by Drug Type
7.3.3. Market by Service
7.3.4. Market by End-User
7.3.5. Country Analysis
7.3.5.1. China
7.3.5.2. India
7.3.5.3. Japan
7.3.5.4. South Korea
7.3.5.5. Australia & New Zealand
7.3.5.6. Asean Countries
7.3.5.7. Rest of Asia-Pacific
7.4. Latin America
7.4.1. Market by Technology
7.4.2. Market by Drug Type
7.4.3. Market by Service
7.4.4. Market by End-User
7.4.5. Country Analysis
7.4.5.1. Brazil
7.4.5.2. Mexico
7.4.5.3. Rest of Latin America
7.5. Middle East and Africa
7.5.1. Market by Technology
7.5.2. Market by Drug Type
7.5.3. Market by Service
7.5.4. Market by End-User
7.5.5. Country Analysis
7.5.5.1. Saudi Arabia
7.5.5.2. Turkey
7.5.5.3. United Arab Emirates
7.5.5.4. South Africa
7.5.5.5. Rest of Middle East & Africa

8. Company Profiles
8.1. 3M Company
8.2. Abbott Laboratories Inc
8.3. Agilent Technologies Inc
8.4. Antares Pharma Inc
8.5. Astrazeneca plc
8.6. Bayer AG
8.7. Becton Dickinson & Company (Bd)
8.8. Boehringer Ingelheim
8.9. Eli Lily and Company
8.10. F Hoffmann-La Roche Ltd
8.11. GlaxoSmithKline LLC
8.12. Johnson & Johnson
8.13. Merck & Co Inc
8.14. Novartis
8.15. Pfizer Inc
8.16. Sanofi

9. Research Methodology & Scope
9.1. Research Scope & Deliverables
9.1.1. Objectives of Study
9.1.2. Scope of Study
9.2. Sources of Data
9.2.1. Primary Data Sources
9.2.2. Secondary Data Sources
9.3. Research Methodology
9.3.1. Evaluation of Proposed Market
9.3.2. Identification of Data Sources
9.3.3. Assessment of Market Determinants
9.3.4. Data Collection
9.3.5. Data Validation & Analysis

List of Tables
Table 1 Global Drug Discovery Market, by Region, 2019-2028 ($ Million)
Table 2 Global Drug Discovery Market, by Drug Type, 2019-2028 ($ Million)
Table 3 Global Drug Discovery Market, by Technology, 2019-2028 ($ Million)
Table 4 Global Drug Discovery Market, by Service, 2019-2028 ($ Million)
Table 5 Global Drug Discovery Market, by End-User, 2019-2028 ($ Million)
Table 6 Global Drug Discovery Market, by Region, 2019-2028 ($ Million)
Table 7 North America Drug Discovery Market, by Technology, 2019-2028 ($ Million)
Table 8 North America Drug Discovery Market, by Drug Type, 2019-2028 ($ Million)
Table 9 North America Drug Discovery Market, by Service, 2019-2028 ($ Million)
Table 10 North America Drug Discovery Market, by End-User, 2019-2028 ($ Million)
Table 11 North America Drug Discovery Market, by Country, 2019-2028 ($ Million)
Table 12 Europe Drug Discovery Market, by Technology, 2019-2028 ($ Million)
Table 13 Europe Drug Discovery Market, by Drug Type, 2019-2028 ($ Million)
Table 14 Europe Drug Discovery Market, by Service, 2019-2028 ($ Million)
Table 15 Europe Drug Discovery Market, by End-User, 2019-2028 ($ Million)
Table 16 Europe Drug Discovery Market, by Country, 2019-2028 ($ Million)
Table 17 Asia-Pacific Drug Discovery Market, by Technology, 2019-2028 ($ Million)
Table 18 Asia-Pacific Drug Discovery Market, by Drug Type, 2019-2028 ($ Million)
Table 19 Asia-Pacific Drug Discovery Market, by Service, 2019-2028 ($ Million)
Table 20 Asia-Pacific Drug Discovery Market, by End-User, 2019-2028 ($ Million)
Table 21 Asia-Pacific Drug Discovery Market, by Country, 2019-2028 ($ Million)
Table 22 Latin America Drug Discovery Market, by Technology, 2019-2028 ($ Million)
Table 23 Latin America Drug Discovery Market, by Drug Type, 2019-2028 ($ Million)
Table 24 Latin America Drug Discovery Market, by Service, 2019-2028 ($ Million)
Table 25 Latin America Drug Discovery Market, by End-User, 2019-2028 ($ Million)
Table 26 Latin America Drug Discovery Market, by Country, 2019-2028 ($ Million)
Table 27 Middle East and Africa Drug Discovery Market, by Technology, 2019-2028 ($ Million)
Table 28 Middle East and Africa Drug Discovery Market, by Drug Type, 2019-2028 ($ Million)
Table 29 Middle East and Africa Drug Discovery Market, by Service, 2019-2028 ($ Million)
Table 30 Middle East and Africa Drug Discovery Market, by End-User, 2019-2028 ($ Million)
Table 31 Middle East and Africa Drug Discovery Market, by Country, 2019-2028 ($ Million)

List of Figures
Figure 1 Global Drug Discovery Market, by Region, 2019-2028 ($ Million)
Figure 2 Global Drug Discovery Market, by Small Molecule Drug, 2019-2028 ($ Million)
Figure 3 Global Drug Discovery Market, by Biologic Drug, 2019-2028 ($ Million)
Figure 4 Global Drug Discovery Market, by High Throughput Screening, 2019-2028 ($ Million)
Figure 5 Global Drug Discovery Market, by Biochips, 2019-2028 ($ Million)
Figure 6 Global Drug Discovery Market, by Bioinformatics, 2019-2028 ($ Million)
Figure 7 Global Drug Discovery Market, by Pharmacogenomics and Pharmacogenetics, 2019-2028 ($ Million)
Figure 8 Global Drug Discovery Market, by Combinatorial Chemistry, 2019-2028 ($ Million)
Figure 9 Global Drug Discovery Market, by Nanotechnology, 2019-2028 ($ Million)
Figure 10 Global Drug Discovery Market, by Spectroscopy, 2019-2028 ($ Million)
Figure 11 Global Drug Discovery Market, by Metabolomics, 2019-2028 ($ Million)
Figure 12 Global Drug Discovery Market, by Other Technologies, 2019-2028 ($ Million)
Figure 13 Global Drug Discovery Market, by Drug Metabolism and Pharmacokinetics (Dmpk) Services, 2019-2028 ($ Million)
Figure 14 Global Drug Discovery Market, by Chemical Services, 2019-2028 ($ Million)
Figure 15 Global Drug Discovery Market, by Biological Services, 2019-2028 ($ Million)
Figure 16 Global Drug Discovery Market, by Other Pharmaceutical Services, 2019-2028 ($ Million)
Figure 17 Global Drug Discovery Market, by Research Institutes, 2019-2028 ($ Million)
Figure 18 Global Drug Discovery Market, by Pharmaceutical Companies, 2019-2028 ($ Million)
Figure 19 Global Drug Discovery Market, by Contract Research Organizations (Cros), 2019-2028 ($ Million)
Figure 20 Global Drug Discovery Market, by Other End-Users, 2019-2028 ($ Million)
Figure 21 United States Drug Discovery Market 2019-2028 ($ Million)
Figure 22 Canada Drug Discovery Market 2019-2028 ($ Million)
Figure 23 the United Kingdom Drug Discovery Market 2019-2028 ($ Million)
Figure 24 France Drug Discovery Market 2019-2028 ($ Million)
Figure 25 Germany Drug Discovery Market 2019-2028 ($ Million)
Figure 26 Spain Drug Discovery Market 2019-2028 ($ Million)
Figure 27 Italy Drug Discovery Market 2019-2028 ($ Million)
Figure 28 Russia Drug Discovery Market 2019-2028 ($ Million)
Figure 29 Rest of Europe Drug Discovery Market 2019-2028 ($ Million)
Figure 30 China Drug Discovery Market 2019-2028 ($ Million)
Figure 31 India Drug Discovery Market 2019-2028 ($ Million)
Figure 32 Japan Drug Discovery Market 2019-2028 ($ Million)
Figure 33 South Korea Drug Discovery Market 2019-2028 ($ Million)
Figure 34 Australia & New Zealand Drug Discovery Market 2019-2028 ($ Million)
Figure 35 Asean Countries Drug Discovery Market 2019-2028 ($ Million)
Figure 36 Rest of Asia-Pacific Drug Discovery Market 2019-2028 ($ Million)
Figure 37 Brazil Drug Discovery Market 2019-2028 ($ Million)
Figure 38 Mexico Drug Discovery Market 2019-2028 ($ Million)
Figure 39 Rest of Latin America Drug Discovery Market 2019-2028 ($ Million)
Figure 40 Saudi Arabia Drug Discovery Market 2019-2028 ($ Million)
Figure 41 Turkey Drug Discovery Market 2019-2028 ($ Million)
Figure 42 United Arab Emirates Drug Discovery Market 2019-2028 ($ Million)
Figure 43 South Africa Drug Discovery Market 2019-2028 ($ Million)
Figure 44 Rest of Middle East & Africa Drug Discovery Market 2019-2028 ($ Million)
Note: Product cover images may vary from those shown
  • 3M Company
  • Abbott Laboratories Inc
  • Agilent Technologies Inc
  • Antares Pharma Inc
  • Astrazeneca plc
  • Bayer AG
  • Becton Dickinson & Company (Bd)
  • Boehringer Ingelheim
  • Eli Lily and Company
  • F Hoffmann-La Roche Ltd
  • GlaxoSmithKline LLC
  • Johnson & Johnson
  • Merck & Co Inc
  • Novartis
  • Pfizer Inc
  • Sanofi
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll